FDA Inspection 1305538 — Innovative Blood Resources, A Division Of New York Blood Center, Inc.
The FDA completed an inspection of Innovative Blood Resources, A Division Of New York Blood Center, Inc. on Feb 13, 2026 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 13, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Omaha, NE (United States)